Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Phivida Holdings Inc. PHVAF

Healthcare Drug Manufacturers - Major Drug Manufacturers - Specialty & Generic Cannabis
Phivida is a premier brand of cannabidiol ('CBD')-infused functional foods, beverages and clinical products that is poised for global distribution.


OTCQX:PHVAF - Post by User

Phivida Holdings Inc. > $7500 ?
<< Previous
 Bullboard Posts
Next >>
User Avatar Image
(0)
•••
Comment by Bleacher1on Aug 01, 2018 5:32am
92 Views
Post# 28396024

RE:$7500 ?

RE:$7500 ?
Gription wrote: Are you serious? They really only sold $7500 worth of products last quarter ? If that’s accurate the sp will remain soft for a very long time. What are your thoughts, Bleacher1 ?


Well at least we didn't blow 36,000,000 up our nose like some others reported Dollar lost is gone forever
<< Previous
 Bullboard Posts
Next >>
Dealroom for high-potential pre-IPO opportunities